Pharma Industry News

Johnson & Johnson lose US bankruptcy bid

Written by David Miller

A US federal appeals court in Philadelphia has denied pharma giant Johnson & Johnson’s (J&J) bankruptcy petition, which aimed to transfer thousands of legal claims against its subsidiary LTL management regarding the claim that its talcum powder causes cancer.

The three-judge panel ruled in favour of the cancer victims who stated that J&J wrongly put LTL management into bankruptcy, allowing it court protection, so courts were unable to hear the 40,000 claims against it.

read more

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]